Correlation Between Ascelia Pharma and NextCell Pharma
Can any of the company-specific risk be diversified away by investing in both Ascelia Pharma and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascelia Pharma and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascelia Pharma AB and NextCell Pharma AB, you can compare the effects of market volatilities on Ascelia Pharma and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascelia Pharma with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascelia Pharma and NextCell Pharma.
Diversification Opportunities for Ascelia Pharma and NextCell Pharma
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ascelia and NextCell is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Ascelia Pharma AB and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and Ascelia Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascelia Pharma AB are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of Ascelia Pharma i.e., Ascelia Pharma and NextCell Pharma go up and down completely randomly.
Pair Corralation between Ascelia Pharma and NextCell Pharma
Assuming the 90 days trading horizon Ascelia Pharma is expected to generate 15.9 times less return on investment than NextCell Pharma. But when comparing it to its historical volatility, Ascelia Pharma AB is 2.05 times less risky than NextCell Pharma. It trades about 0.02 of its potential returns per unit of risk. NextCell Pharma AB is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 180.00 in NextCell Pharma AB on November 2, 2024 and sell it today you would earn a total of 112.00 from holding NextCell Pharma AB or generate 62.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ascelia Pharma AB vs. NextCell Pharma AB
Performance |
Timeline |
Ascelia Pharma AB |
NextCell Pharma AB |
Ascelia Pharma and NextCell Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ascelia Pharma and NextCell Pharma
The main advantage of trading using opposite Ascelia Pharma and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascelia Pharma position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.Ascelia Pharma vs. Hansa Biopharma AB | Ascelia Pharma vs. Cantargia AB | Ascelia Pharma vs. Saniona AB | Ascelia Pharma vs. BioArctic AB |
NextCell Pharma vs. Diamyd Medical AB | NextCell Pharma vs. Mendus AB | NextCell Pharma vs. Vicore Pharma Holding | NextCell Pharma vs. Immunovia publ AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |